Clinical Trials Browser

Phase 3 × Olanzapine × 90 days × Clear all

NCT04939090 2026-03-04

Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

Phase 3 Recruiting

Other hematologic neoplasm

Anorexia, Hematologic Neoplasms

NCT06200181 2026-02-13

Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial

Phase 3 Recruiting

Opioid-Related Disorders